This month, AMA Journal of Ethics theme editor Jacquelyn Nestor, a fifth-year MD/PhD student at Hofstra-Northwell School of Medicine, interviewed Allen Buchanan, PhD, about how we can safely explore cutting-edge biomedical enhancements.
Because knowledge about the efficacy of long-term opioid use is lacking, decisions about opioid treatment for chronic nonmalignant pain should be guided by a six-step decision making process that is based in clinical ethics.
AMA J Ethics. 2015;17(6):521-529. doi:
10.1001/journalofethics.2015.17.6.nlit1-1506.
This month theme issue editor, Trahern Jones, a fourth-year student at Mayo Medical School in Rochester, Minnesota, spoke with Dr. Edward Laskowski about the use of performance-enhancing drugs and substances among athletes today.
Julian Savulescu's writing on conscientious objection is guided by an emphasis on the principle of distributive justice that does not allow religion to have a special status as justification.
Patients’ personal or cultural views toward illness, the business of health care under which we all operate, and our own personal opinions about the ideal of health and wellness can all compromise pain treatment. It is our responsibility to see that it does not.
For patients to adopt personal health records, they must be convinced of the value the technology has for them. Framing that value in a way that actively engages patients as collaborators in their health care management will not only empower the individual but improve patient-clinician relationships overall.
Smartphone- and tablet-based medical devices and apps have significant potential to affect the patient-clinician relationship and improve the efficiency of the health care system.
Concerns about the deleterious effects of stress on the mind and body have led to the beginnings of a stress vaccine, an injection that will reduce these effects.